NCT01186224
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- Dept of Haematology, University of Liverpool Liverpool, Merseyside, United Kingdom
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
145 public trials
32 recruiting studies
Lymphoproliferative Disorders trial results
NCT03744676
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Local Institution - 0057 Los Angeles, California, United States
- Local Institution - 0060 Denver, Colorado, United States
- Local Institution - 0089 Miami, Florida, United States
- Local Institution - 0081 Orlando, Florida, United States
NCT06690814
- Conditions
- Cutaneous Ulcer Disease, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
- Locations
-
- Vunapope Hospital Kokopo, EAST NEW Britan, Papua New Guinea
NCT01183949
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana Faber Cancer Institute Boston, Massachusetts, United States
- Memorial Sloan-Kettering Cancer Centre New York, United States
Completed
Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05)
NCT02658968
- Conditions
- AIDS-Related Complex, Blood-Borne Infections, Communicable Diseases, +29 more
- Locations
-
- University of California, San Diego (UCSD) - Moores Cancer Center San Diego, California, United States
- University of California, San Francisco (UCSF) - Innovation, Technology & Alliances San Francisco, California, United States
- Sylvester Comprehensive Cancer Centre Miami, Florida, United States
- Klinikum rechts der Isar der TU München Munich, Germany
NCT06042400
- Conditions
- Anxiety, Anxiety Disorders, Fear of Cancer Progression, +14 more
- Locations
-
- University of Colorado Boulder Boulder, Colorado, United States
Completed
Leflunomide for the Treatment of Relapsed or Refractory CD30+ Lymphoproliferative Disorders
NCT04463615
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +4 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT02733042
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +20 more
- Locations
-
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Pinnacle Oncology Hematology Scottsdale, Arizona, United States
- University of Colorado Cancer Center Aurora, Colorado, United States
- Shands Cancer Center University of Florida Gainesville, Florida, United States
Completed
Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
NCT01000753
- Conditions
- Adult Immunoblastic Lymphoma, Central Nervous System Non-Hodgkin Lymphoma, Childhood Immunoblastic Lymphoma, +35 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
- Arkansas Children's Hospital Little Rock, Arkansas, United States
NCT03513328
- Conditions
- Acquired Anemia Hemolytic, Acquired Neutropenia in Newborn, Acquired Thrombocytopenia, +82 more
- Locations
-
- UF Health Shands Children's Hospital Gainesville, Florida, United States